Regenerative biologics distributor for Omaha medspas and dermatology

Who can open an account

Ordering is restricted to accounts verified against a licensed physician's NPI number, consistent with selling only to licensed clinics, physicians and physician-supervised medspas. For a medspa, the supervising physician's NPI anchors the account, and the physician is responsible for how any product ordered under that account is used.

• Supervising physician's NPI number
• Practice or medspa business details
• Confirmation of physician supervision for medspa accounts

Cold-chain and shelf-stable shipping options

Cryopreserved Wharton's jelly formats ship overnight at -80 degrees Celsius on dry ice in validated containers, which requires a staff member on hand to receive and log the delivery the day it arrives. Lyophilized Wharton's jelly and exosome formats skip that step, since they are shelf-stable at room temperature according to the insert that accompanies each lot, which some medspas prefer for inventory simplicity.

Documentation and Nebraska-specific verification

Each lot carries a unique identifier tying it back to donor screening and third-party sterility testing records, which a verified account can request as a certificate of analysis or lot release record. FDA has stated there are no FDA-approved exosome products, and Wharton's jelly allografts are supplied under the distributor's HCT/P framework; a medical director should confirm with the Nebraska medical board and the practice's own counsel how a specific intended use is classified before ordering.

Evaluating a biologics distributor as a medspa or dermatology practice

A dermatology practice or medspa comparing suppliers typically asks about donor consent and screening, whether every lot completes sterility testing before leaving quarantine, and whether a physician can get a documentation-focused conversation rather than a sales pitch. Those questions apply the same way to a Wharton's jelly product and to an exosome product, even though the two are regulated differently.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.